Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
Funded at University of Louisiana at Lafayette · NIH-10138761 · Data updated 2026-11-12
This study is looking at how well different vaccines can work to prevent HIV by testing them on nonhuman primates, which helps researchers find the best options for people living with or at risk of HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2020 |
| Award (this year) | $124,067 |
| NIH project number | 75N93020D00008-0-759302000003-1 |
| Project ID | NIH-10138761 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV who may eventually receive effective vaccines developed through these studies.
✕Less likely to help
Patients who are not at risk for HIV or those who are already living with HIV may not directly benefit from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines and prevention strategies for HIV. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for researchers to conduct thorough assessments of immune responses and vaccine efficacy. By utilizing these primates, the research aims to identify effective vaccines that can prevent or control HIV infection. The program supports all stages of AIDS vaccine research, from preclinical evaluations to clinical testing.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly improving public health outcomes.
How similar studies have gone: Other research has shown success in using nonhuman primates for vaccine evaluation, indicating that this approach is both established and promising.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.